The Brazil contraceptives devices market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 7% during 2023–2031. The growth of the market is attributed to the increasing patient awareness huge untapped opportunities, economic development, and continuous improvement of health infrastructure.
Contraception is the prevention of pregnancy through the use of drugs, barriers, medical devices, and surgical methods to interfere with ovulation, implantation, and fertilization. These drugs are drugs that inhibit sexually transmitted diseases. The increasing prevalence of sexually transmitted diseases such as gonorrhea, chlamydia, hepatitis B, and HIV worldwide is one of the key factors driving market. Unexpected pregnancy is the major factor driving market. Some governments in developed and developing countries are also carrying out advocacy activities and promoting the use of effective contraceptives, especially in rural areas, to control populations and prevent the spread of sexually transmitted diseases. This has led to a significant increase in the demand for easy-to-use, removable, and inexpensive contraceptives.
The contraceptive market has multiple distribution channels, including hospital pharmacies, retail pharmacies, clinics, online channels, community channels, and non-governmental organizations. Contraceptive measures for healthcare professionals and the government’s active support for the distribution of contraceptives through government-subsidized hospitals the market is expected to grow significantly in the next few years.
Brazil Contraceptives Devices Market Trends, Drivers, Restraints, and Opportunities
-
Rising adoption of contraceptive devices for preventing unwanted pregnancy and focus on family planning is expected to boost the market during the forecast period.
-
Rapid growth of the contraceptive industry owing to free distribution of contraceptive devices in hospitals, villages, and government initiatives is major factors fueling the market.
-
Increasing awareness among females about health effects on teenage pregnancies and demand for oral pills is anticipated to drive the market during forecast period.
-
High risk of health effects associated with use of contraceptive devices such as hormonal imbalance and availability of alternative contraceptive methods is projected to restrict the market growth.
-
Lacks of awareness and social acceptance on the use of contraceptive devices act as major factors that can hamper the market growth during the forecast period.
-
R&D investment and development in contraceptive products to minimize the health effects after consumption is expected to offer significant opportunities for the market players.
Scope of Brazil Contraceptives Devices Market Report
The report on the Brazil contraceptive devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Brazil Contraceptive Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Types (Condoms, Cervical Caps, Vaginal Rings, Diaphragms, Sponges, Intra-uterine Devices, and Others), and Gender (Male and Female)
|
|
Geography
|
Brazil
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Veru Inc. (The Female Health Co.); Church & Dwight Co., Inc.; Allergan PLC; The Cooper Companies Inc.; and Bayer AG
|
Brazil Contraceptives Devices Market Segment Insights
The condom segment is projected to represent a major market share
Based on types, the Brazil contraceptives devices market is divided into condoms, cervical caps, vaginal rings, diaphragms, sponges, intra-uterine devices, and others. The condom segment is expected to hold a key share of the market in the coming years. Condom is a protective device used to reduce the chance of pregnancy or a sexually transmitted infection (STI). Both men and women have condoms.
Their use significantly reduces the risk of gonorrhea, chlamydia, and hepatitis B. Therefore, as the number of sexually transmitted diseases increases the demand for contraception increases and eventually drives the market. On the other hand, the intra-uterine devices segment is anticipated to expand at a rapid pace during the forecast period owing to the rapid increase in unwanted pregnancies. The introduction of affordable healthcare is expected to drive the market. Side effects related to the intrauterine device are estimated to be an important factor driving the intrauterine device market.
The female segment is expected to register at a significant pace
On the basis of gender, the market is bifurcated into male and female. The female segment is expected to represent a key share of the market during the forecast period owing to the availability of a variety of female contraceptives and widespread use of intrauterine devices. There are commercial female contraceptives in the market, including vaginal rings, intrauterine devices, subcutaneous implants, female condoms, diaphragms, and sponges.
Segments
The Brazil contraceptive devices market has been segmented on the basis of
Types
- Condoms
- Cervical Caps
- Vaginal Rings
- Diaphragms
- Sponges
- Intra-uterine Devices
- Others
Gender
Key Players
- Veru Inc. (The Female Health Co.)
- Church & Dwight Co., Inc.
- Allergan PLC
- The Cooper Companies Inc.
- Bayer AG
Competitive Landscape
Key players competing in the Brazil contraceptive devices market include Veru Inc. (The Female Health Co.); Church & Dwight Co., Inc.; Allergan PLC; The Cooper Companies Inc.; and Bayer AG.
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
